Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-22

Clinical Trial Update: Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating mycophenolate mofetil (MMF) in treating idiopathic inflammatory myopathy-associated interstitial lung disease and its effect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Idiopathic Inflammatory Myopathy, Interstitial Lung Disease | Phase 4 | Status: UNKNOWN